EUVIMEDEUVIMED entdecken
Open Access

Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD

Romit Bhattacharya iD, Christopher S Marnell iD, So Mi Jemma Cho iD, Aniruddh P Patel iD, Yunfeng Ruan iD, Satoshi Koyama iD, Amanda R Jowell iD, Mark Trinder iD, Sara Haidermota iD, Kim Lannery, Michael C Honigberg iD, Seyedeh M Zekevat und 3 weitere

Circulation: Genomic and Precision Medicine · 2025-08 · 18 (4)

DOI: 10.1161/circgen.124.004937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2025-08. Verfasst von Romit Bhattacharya und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Harvard Medical School (R.B., A.P., A.J., S.H., K.L., M.C.H., P.N.), Massachusetts General Hospital, Boston. Hauptthemen laut MEDLINE: Coronary Artery Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prior work suggests modifiable cardiovascular risk factors (CRFs) account for 80% to 90% of the risk for incident myocardial infarction. The contributions of genetic and other novel CRFs have not been simultaneously assessed in contemporary data sets. METHODS: In the United Kingdom Biobank, CRFs were identified and Cox proportional hazards models with traditional CRFs (hypertension, diabetes, dyslipidemia, waist-to-hip ratio, diet, exercise, alcohol, and socioeconomic deprivation) and contemporary/genetic CRFs (Lp(a) [lipoprotein(a)], hsCRP [high-sensitivity C-reactive protein], familial hypercholesterolemia variants, and polygenic risk score for coronary artery disease) were constructed for coronary artery disease. Coronary artery disease was defined as a first-time myocardial infarction diagnosis or coronary revascularization. R 2 was calculated for each model, and the percent contribution of each individual CRF was calculated by the R 2 percent decrease after its removal. RESULTS: Among 299 707 individuals, the mean (SD) age was 56.2 (8.1) years, and 166 533 (55.6%) were women. Over a median (interquartile range) follow-up of 11.0 (9.6–12.5) years, 17 409 (5.8%) of participants developed myocardial infarction. R 2 increased from the base model (R 2 , 0.021 [0.020–0.022]), to the clinical model (R 2 , 0.045 [0.043–0.046]), to the contemporary/genetic model (R 2 , 0.053 [0.052–0.055]). The most powerful individual CRFs were hypertension (R 2 loss, 15.2% [14.5–17.1]) and polygenic risk score for coronary artery disease (R 2 loss, 12.4% [10.8–13.3]), followed by dyslipidemia (R 2 loss, 3.4% [2.6–3.5]), diabetes (R 2 loss, 2.2% [1.5–2.0]), hsCRP (R 2 loss, 1.8% [1.5–2.0]), and Lp(a) (R 2 loss, 1.5% [1.2–1.8]). CONCLUSIONS: Novel CRFs like polygenic risk score for coronary artery disease, hsCRP, and Lp(a) have similar importance, comparable to traditional CRFs such as hypertension, dyslipidemia, and diabetes, for incident myocardial infarction, highlighting important identifiable residual risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseHumansFemaleMaleMiddle AgedRisk FactorsAgedIncidenceUnited KingdomMyocardial InfarctionGenetic Predisposition to DiseaseHeart Disease Risk FactorsProportional Hazards ModelsHypertensionMultifactorial Inheritance

Stichwörter der Autor:innen

dyslipidemiasgenetic risk scoreheart disease risk factorshypertensionmyocardial infarctionprimary prevention

Autor:innen und Institutionen

  • Department of Medicine, Harvard Medical School (R.B., A.P., A.J., S.H., K.L., M.C.H., P.N.), Massachusetts General Hospital, Boston.
  • Department of Medicine, Cardiovascular Research Center & Center for Genomic Medicine (R.B., S.M.J.C., A.P., Y.R., S.K., M.K., S.H., K.L., M.C.H., S.M.Z., P.N.), Massachusetts General Hospital, Boston.
  • The Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (C.S.M.).
  • Integrative Research Center for Cerebrovascular & Cardiovascular Diseases, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea (S.M.J.C.).
  • Program in Medical and Population Genetics & Cardiovascular Disease Initiative, Broad Institute of Harvard & MIT, Cambridge (A.P., Y.R., S.K., M.T., S.H., K.L., M.C.H., S.M.Z., I.S., P.N.).
  • Department of Medicine, Brigham and Women's Hospital, Boston, MA (A.J.).

ORCID-Profile: Romit Bhattacharya, Christopher S Marnell, So Mi Jemma Cho, Aniruddh P Patel, Yunfeng Ruan, Satoshi Koyama, Amanda R Jowell, Mark Trinder, Sara Haidermota, Michael C Honigberg, Ida Surakka, Gina M Peloso, Pradeep Natarajan

Förderung

  • NHGRI NIH HHS
  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Bhattacharya, R., Marnell, C. S., Cho, S. M. J., Patel, A. P., Ruan, Y., Koyama, S., Jowell, A. R., Trinder, M., Haidermota, S., Lannery, K., Honigberg, M. C., Zekevat, S. M., Surakka, I., Peloso, G. M., & Natarajan, P. (2025). Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD. Circulation: Genomic and Precision Medicine, 18(4). https://doi.org/10.1161/circgen.124.004937

Vancouver

Bhattacharya R, Marnell CS, Cho SMJ, Patel AP, Ruan Y, Koyama S, et al. Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD. Circulation: Genomic and Precision Medicine. 2025;18(4). doi:10.1161/circgen.124.004937

BibTeX
@article{Bhattacharya2025,
  author = {Bhattacharya, Romit and Marnell, Christopher S and Cho, So Mi Jemma and Patel, Aniruddh P and Ruan, Yunfeng and Koyama, Satoshi and Jowell, Amanda R and Trinder, Mark and Haidermota, Sara and Lannery, Kim and Honigberg, Michael C and Zekevat, Seyedeh M and Surakka, Ida and Peloso, Gina M and Natarajan, Pradeep},
  title = {Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2025},
  volume = {18},
  number = {4},
  doi = {10.1161/circgen.124.004937}
}
Kostenlos starten →